Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Analytical Biochemistry|August 26, 1998
Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusionsE Brouwer, J Verweij, B Hauns, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|February 12, 2000
Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatographyW J Loos, P de Bruijn, L van Zuylen, et al.
Analytical Biochemistry|March 30, 1999
Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatographyP de Bruijn, M J de Jonge, J Verweij, et al.
Leukemia|June 1, 1994
Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemiasH Burger, K Nooter, G J Zaman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
International Journal of Cancer|April 15, 1990
Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulationK Nooter, P Sonneveld, A Janssen, et al.
International Journal of Cancer|February 20, 1992
SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemiaR P Keller, H J Altermatt, K Nooter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxelHans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 11, 1998
Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and fecesA Sparreboom, P de Bruijn, M J de Jonge, et al.
Blood|July 15, 2004
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpHerman Burger, Hans van Tol, Antonius W M Boersma, et al.
Pageof 14